Safety & Efficacy of Pilocarpine Ophthalmic Spray for Temporary Improvement of Near Vision in Presbyopic Adults
Status:
Recruiting
Trial end date:
2022-04-30
Target enrollment:
Participant gender:
Summary
Volunteer participants are evaluated for eligibility during a Screening Visit; those meeting
study inclusion/exclusion criteria are scheduled for 2 treatment visits. At each treatment
visit, 1 of the 2 study treatments is self-administered to both eyes. Afterwards, efficacy
and safety assessments are performed over a 3-hour period.